Salesforce beats on earnings, issues better-than-expected revenue forecast

Salesforce reported adjusted EPS of $3.25 versus LSEG consensus of $2.86 and revenue of $10.26 billion roughly in line with the $10.27 billion estimate, with revenue up 8.6% year-over-year and net income of $2.09 billion ($2.19/share) aided by a $263 million strategic-investment gain. Management guided fiscal Q4 to $3.02–$3.04 adjusted EPS and $11.13–$11.23 billion revenue (implying 11–12% growth, ~3 points from the Informatica acquisition), while free cash flow of $2.18 billion missed the StreetAccount $2.24 billion consensus; the company also highlighted strong traction in Agentforce (annualized revenue >$500M, up 330%) and recent AI-focused acquisitions. These results and upbeat revenue guidance are supportive for the stock despite ongoing AI-related product-concern headwinds and substantial YTD share weakness.

Analysis

Market structure: Salesforce (CRM) shows durable enterprise demand — Q4 guide implies 11–12% revenue growth with ~3 pts from Informatica and Agentforce ARR >$500M (330% YoY). Winners are CRM, AI-enabled data-management providers and infrastructure vendors (NVDA, cloud). Losers: pure-play legacy ITSM vendors and smaller SaaS names with weak AI roadmaps that risk share loss and pricing pressure.

Risk assessment: Near-term risk: misses to FCF/earnings or integration costs from Informatica could re-price CRM (days–months). Tail risks include regulatory limits on AI features, large client churn, or failed integrations (low probability, high impact). Hidden dependency: a sizable portion of growth is M&A-driven and adoption of Agentforce; failure to convert demos to net-new ARR would slow organic growth (quarterly cadence).

Trade implications: Direct longs on CRM capture re-rating if Agentforce and integration deliver; pair trades long CRM vs short ServiceNow (NOW) exploit relative exposure to ITSM. Options: use 6–12 month call spreads to limit downside while keeping upside to guidance beats. Rotate from high-multiple, non-AI SaaS into AI infrastructure and CRM within 2–6 months.

Contrarian angles: Market is pricing substantial AI substitution risk into CRM (shares -29% YTD vs Nasdaq +21%), which likely overstates near-term product obsolescence given accelerating paid deals (9.5k) and Agentforce revenue ramp. If CRM hits >$1B ARR from Agentforce within 4 quarters, consensus will re-rate; conversely, over-optimistic 2030 $60B target is a long-duration optionality that can disappoint and should be de-risked with clear cadence milestones.

Key Decisions for Investors

• Establish a 2–3% long position in CRM within the next 5 trading days on any intraday weakness; set a 3–6 month target of +12–18% and a hard stop-loss at -15% to limit downside if FCF/guidance momentum stalls.
• Implement a relative-value pair: long CRM (2% portfolio) vs short NOW (2% portfolio) to exploit Agentforce-led share gains in ITSM; unwind or rebalance if the pair moves against you by 15% or after CRM's next quarterly report.
• Buy a 9–12 month CRM call spread (buy 10% OTM, sell 25% OTM) risking ~0.5–1% of portfolio capital to capture upside from product adoption and guidance execution; take profits on a 20% absolute move in CRM or on a positive quarterly print.
• Reduce exposure by ~20% to high-multiple pure-play SaaS names that lack clear enterprise AI roadmaps (rotate proceeds into CRM and AI infrastructure like NVDA) over the next 4–8 weeks, reassessing after CRM delivers two consecutive quarters of Agentforce ARR progression.